SEVERE SIDE-EFFECTS WITH THE APPLICATION OF MESALAZINE (5-AMINOSALICYLIC ACID) DURING RADIOTHERAPY

被引:0
|
作者
FREUND, U
SCHOLMERICH, J
SIEMS, H
KLUGE, F
SCHAFER, HE
WANNENMACHER, M
机构
来源
STRAHLENTHERAPIE UND ONKOLOGIE | 1987年 / 163卷 / 10期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:678 / 680
页数:3
相关论文
共 50 条
  • [21] Role of Organic Anion-Transporting Polypeptides for Cellular Mesalazine (5-Aminosalicylic Acid) Uptake
    Koenig, Joerg
    Glaeser, Hartmut
    Keiser, Markus
    Mandery, Kathrin
    Klotz, Ulrich
    Fromm, Martin F.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (06) : 1097 - 1102
  • [22] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Karamanolis, DG
    Papatheodoridis, GV
    Xourgias, V
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (11) : 1083 - 1088
  • [23] RETROGRADE SPREAD OF MESALAZINE (5-AMINOSALICYLIC ACID)-CONTAINING ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS
    TIELVANBUUL, MMC
    MULDER, CJJ
    VANROYEN, EA
    WILTINK, EHH
    TYTGAT, GNJ
    CLINICAL PHARMACOKINETICS, 1991, 20 (03) : 247 - 251
  • [24] DELAYED-RELEASE MESALAZINE (5-AMINOSALICYLIC ACID) - COAT DISSOLUTION AND EXCRETION IN ILEOSTOMY SUBJECTS
    RILEY, SA
    TAVARES, IA
    BENNETT, A
    MANI, V
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (02) : 173 - 177
  • [25] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Tzivras, M
    Konstandinidis, A
    Hatzis, G
    Paraskeva, K
    Skandalis, N
    Archimandritis, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (07) : 729 - 730
  • [26] ORAL MESALAZINE (5-AMINOSALICYLIC ACID - ASACOL) FOR THE PREVENTION OF POSTOPERATIVE RECURRENCE OF CROHNS-DISEASE
    CAPRILLI, R
    ANDREOLI, A
    CAPURSO, L
    CORRAO, G
    DALBASIO, G
    GIOIENI, A
    LANFRANCHI, GA
    PALADINI, I
    PALLONE, F
    PONTI, V
    RIGO, GP
    ROSSINI, FP
    STURNIOLO, GC
    TONELLI, F
    VALPIANI, D
    LATELLA, G
    FRIERI, G
    VERNIA, P
    VISCIDO, A
    VALENTI, M
    TORCHIO, P
    TRAGNONE, A
    SALVADORI, G
    FERRETTI, P
    VANNOZZI, G
    MIGLIO, F
    MASTRONARDI, M
    CODELUPPI, PL
    MONTINO, MC
    DINCA, R
    DAGOSTINO, L
    LORENZETTI, R
    CIACO, A
    PAPI, A
    LUMINARI, M
    BERTONE, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 (01) : 35 - 43
  • [27] 5-AMINOSALICYLIC ACID INDUCED AGRANULOCYTOSIS
    Oktay, Ahmet A.
    Albarillo, Fritzie S.
    Dandachi, Dima
    Dowlatshahi, Samaneh
    Raftery, Laura
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S249 - S250
  • [28] PSORIASIS TREATMENT WITH 5-AMINOSALICYLIC ACID
    CORTESFRANCO, R
    FERNANDEZ, LM
    DOMINGUEZSOTO, L
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1994, 33 (08) : 573 - 575
  • [29] In vivo radioprotection by 5-aminosalicylic acid
    Mantena, S. K.
    Unnikrishnan, M. K.
    Joshi, Ravi
    Radha, V.
    Devi, P. Uma
    Mukherjee, T.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2008, 650 (01) : 63 - 79
  • [30] 5-AMINOSALICYLIC ACID ENEMAS - REPLY
    RAITANO, A
    MUSSI, T
    STECCANELLA, S
    STRAZZARI, S
    CAMPIERI, M
    LANFRANCHI, GA
    BRIGNOLA, C
    BAZZOCCHI, G
    LANCET, 1982, 1 (8263): : 102 - 102